126 related articles for article (PubMed ID: 11112512)
1. Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli.
Schmiedl A; Breitling F; Dübel S
Protein Eng; 2000 Oct; 13(10):725-34. PubMed ID: 11112512
[TBL] [Abstract][Full Text] [Related]
2. Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus.
Cai K; Wang H; Bao S; Shi J; Hou X; Gao X; Liu H; Yin J
Microbes Infect; 2008 Apr; 10(5):548-55. PubMed ID: 18424153
[TBL] [Abstract][Full Text] [Related]
3. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
[TBL] [Abstract][Full Text] [Related]
4. Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.
Huang YJ; Chen IC; Yu CM; Lee YC; Hsu HJ; Ching AT; Chang HJ; Yang AS
J Biol Chem; 2010 Mar; 285(11):7880-91. PubMed ID: 20068035
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of bispecific single-chain antibody fragments.
De Jonge J; Brissinck J; Heirman C; Demanet C; Leo O; Moser M; Thielemans K
Mol Immunol; 1995 Dec; 32(17-18):1405-12. PubMed ID: 8643110
[TBL] [Abstract][Full Text] [Related]
6. A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2.
Bera TK; Onda M; Brinkmann U; Pastan I
J Mol Biol; 1998 Aug; 281(3):475-83. PubMed ID: 9698563
[TBL] [Abstract][Full Text] [Related]
7. Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment.
Kobayashi H; Han ES; Kim IS; Le N; Rajagopal V; Kreitman RJ; Pastan I; Paik CH; Carrasquillo JA
Nucl Med Biol; 1998 May; 25(4):387-93. PubMed ID: 9639301
[TBL] [Abstract][Full Text] [Related]
8. Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase.
Atwell JL; Pearce LA; Lah M; Gruen LC; Kortt AA; Hudson PJ
Mol Immunol; 1996 Dec; 33(17-18):1301-12. PubMed ID: 9171890
[TBL] [Abstract][Full Text] [Related]
9. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
[TBL] [Abstract][Full Text] [Related]
11. Phage display of disulfide-stabilized Fv fragments.
Brinkmann U; Chowdhury PS; Roscoe DM; Pastan I
J Immunol Methods; 1995 May; 182(1):41-50. PubMed ID: 7769243
[TBL] [Abstract][Full Text] [Related]
12. Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding.
Davé E; Adams R; Zaccheo O; Carrington B; Compson JE; Dugdale S; Airey M; Malcolm S; Hailu H; Wild G; Turner A; Heads J; Sarkar K; Ventom A; Marshall D; Jairaj M; Kopotsha T; Christodoulou L; Zamacona M; Lawson AD; Heywood S; Humphreys DP
MAbs; 2016 Oct; 8(7):1319-1335. PubMed ID: 27532598
[TBL] [Abstract][Full Text] [Related]
13. Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation.
Reiter Y; Brinkmann U; Jung SH; Pastan I; Lee B
Protein Eng; 1995 Dec; 8(12):1323-31. PubMed ID: 8869646
[TBL] [Abstract][Full Text] [Related]
14. Purification of clinical-grade disulfide stabilized antibody fragment variable--Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli.
Jiang H; Xie Y; Burnette A; Roach J; Giardina SL; Hecht TT; Creekmore SP; Mitra G; Zhu J
Appl Microbiol Biotechnol; 2013 Jan; 97(2):621-32. PubMed ID: 22890777
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
[TBL] [Abstract][Full Text] [Related]
16. Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.
Metz S; Panke C; Haas AK; Schanzer J; Lau W; Croasdale R; Hoffmann E; Schneider B; Auer J; Gassner C; Bossenmaier B; Umana P; Sustmann C; Brinkmann U
Protein Eng Des Sel; 2012 Oct; 25(10):571-80. PubMed ID: 22976197
[TBL] [Abstract][Full Text] [Related]
17. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
[TBL] [Abstract][Full Text] [Related]
18. Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties.
Tsumoto K; Nakaoki Y; Ueda Y; Ogasahara K; Yutani K; Watanabe K; Kumagai I
Biochem Biophys Res Commun; 1994 Jun; 201(2):546-51. PubMed ID: 8002985
[TBL] [Abstract][Full Text] [Related]
19. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
20. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.
Reiter Y; Brinkmann U; Lee B; Pastan I
Nat Biotechnol; 1996 Oct; 14(10):1239-45. PubMed ID: 9631086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
